What are the side effects of oral budesonide?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Side Effects of Oral Budesonide

Oral budesonide has a more favorable side effect profile compared to conventional corticosteroids due to its high first-pass hepatic metabolism, but it still carries risks of both local and systemic adverse effects that require monitoring.

Common Side Effects

  • Headache is one of the most frequently reported side effects, occurring in approximately 11.4% of patients taking budesonide 9 mg daily 1
  • Nausea affects about 5.1% of patients on budesonide 9 mg daily 1
  • Decreased blood cortisol levels occur in approximately 4.3% of patients, reflecting the drug's systemic absorption despite its designed first-pass metabolism 1
  • Upper abdominal pain (3.9%), fatigue (3.1%), flatulence (2.4%), and abdominal distension (2.4%) are common gastrointestinal side effects 1
  • Acne (2.4%), urinary tract infections (2.0%), arthralgia (2.0%), and constipation (2.0%) are also reported in clinical trials 1

Adrenal Suppression and Immunosuppression

  • Adrenal suppression can occur with long-term use, causing symptoms such as tiredness, weakness, nausea, vomiting, and low blood pressure 1
  • Immunosuppression increases the risk of infections from viruses, bacteria, fungi, and parasites 1
  • Budesonide can make current infections worse, increase risk of disseminated infections, reactivate latent infections, and mask signs of infection 1
  • Tuberculosis reactivation is possible in patients with latent TB 1
  • Patients taking budesonide who haven't had chickenpox or measles should avoid contact with people who have these diseases 1
  • Hepatitis B virus reactivation can occur in carriers 1

Special Considerations for Different Conditions

Inflammatory Bowel Disease

  • In ulcerative colitis, budesonide MMX 9 mg daily has been shown to be more effective than placebo with fewer side effects than conventional corticosteroids 2
  • For Crohn's disease, budesonide 9 mg/day is recommended for mild to moderate ileal and/or right colonic disease with fewer systemic side effects than conventional corticosteroids 2

Autoimmune Hepatitis

  • Budesonide may be considered in non-cirrhotic patients with severe steroid-related side effects such as psychosis, poorly controlled diabetes, or osteoporosis 2
  • Reduced liver function affects elimination of budesonide and increases systemic availability, potentially leading to more side effects 1

Eosinophilic Esophagitis

  • Candida infection may occur in approximately 3.6% of patients treated with orodispersible budesonide tablets but can be managed with topical antifungals while continuing budesonide therapy 2

Pregnancy and Lactation Considerations

  • Budesonide is classified as pregnancy category C 2
  • It may lower fetal exposure compared to other corticosteroids and is considered compatible with breastfeeding 2
  • Although older literature reported increased risk of orofacial clefts with first-trimester corticosteroid exposure, more recent data shows no increased risk 2

Long-term and Serious Side Effects

  • Kaposi's sarcoma has been reported in patients receiving corticosteroid therapy, particularly for chronic conditions 1
  • Worsening of allergies may occur if switching from other corticosteroids to budesonide 1
  • Osteoporosis, hypertension, diabetes mellitus, peptic ulcer, glaucoma, and cataracts are potential concerns with long-term use 1
  • In children and adolescents on long-term therapy, monitoring of adrenal gland suppression and bone mineral density is recommended 2

Monitoring Recommendations

  • Regular monitoring of cortisol levels is advised for patients on long-term therapy 2
  • Patients should be monitored for signs and symptoms of infection while taking budesonide 1
  • Patients with reduced liver function require closer monitoring due to increased systemic exposure 1

Contraindications and Cautions

  • Budesonide should be avoided in patients with known or suspected Strongyloides infection as it may lead to dissemination with widespread larval migration 1
  • It should be avoided in patients with cerebral malaria 1
  • Caution is needed in patients with latent amebiasis, especially those who have spent time in the tropics or have unexplained diarrhea 1

Despite these potential side effects, budesonide generally has a more favorable safety profile compared to conventional corticosteroids, making it a valuable option for various inflammatory conditions when systemic steroid effects need to be minimized 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.